Suzhou, China

Liangyou Wang


Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2021

where 'Filed Patents' based on already Granted Patents

1 patent (USPTO):

Title: Innovations of Liangyou Wang in Chemosynthetic Peptides

Introduction

Liangyou Wang is an accomplished inventor based in Suzhou, China. He has made significant contributions to the field of biochemistry, particularly in the development of innovative peptides that have potential pharmaceutical applications. His work focuses on creating solutions that can inhibit harmful toxins, showcasing his commitment to advancing medical science.

Latest Patents

Liangyou Wang holds a patent for a "Chemosynthetic cyclo-hepta modified peptide capable of inhibiting toxins and use thereof." This invention relates to a chemosynthetic peptide that can specifically inhibit the production of toxins through the binding of the RNAIII activator protein. The general formula of this modified peptide is CH—(CH)m-X-G-(CQHWWHWYC)—(R)n-Y. The results indicate that this peptide is well-dissolved in water and exhibits significant activity against toxins.

Career Highlights

Throughout his career, Liangyou Wang has demonstrated a strong focus on innovative research and development. His work has not only contributed to the scientific community but also holds promise for practical applications in the pharmaceutical industry. His dedication to his field is evident in the successful patenting of his inventions.

Collaborations

Liangyou Wang has collaborated with notable colleagues such as Ningsheng Shao and Guang Yang. These partnerships have likely enhanced the scope and impact of his research, fostering an environment of innovation and shared knowledge.

Conclusion

Liangyou Wang's contributions to the field of chemosynthetic peptides represent a significant advancement in the fight against toxins. His innovative approach and successful patent highlight the potential for future developments in pharmaceutical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…